Fresenius Medical Care AG & Co. KGaA ADR (FMS)
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Fresenius Medical Care tops market expectations in 1st quarter
World's largest dialysis specialist Fresenius Medical Care reported first-quarter results above analysts' expectations on Tuesday, as revenue grew organically in all its segments, it said.
Should You Buy, Sell, or Hold FMS Stock Before Q1 Earnings?
Fresenius Medical Care heads into the first quarter of 2025 with momentum from cost savings, innovation like the 5008X launch, and a steady recovery in U.S. treatment volumes.
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Fresenius (FMS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Fresenius Medical Care Stock Might be a Great Pick
FMS has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Here's Why Fresenius (FMS) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are Investors Undervaluing Fresenius Medical Care AG & Co. (FMS) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Reasons to Add Fresenius Medical Stock to Your Portfolio Now
FMS continues to gain traction on the back acquisitions & partnerships. A tough regulatory environment raises concerns.
4 Stocks Trading Near 52-Week High With More Upside Potential
Stocks like TAP, FMS, TGI and THG are seeing price strength and have a high chance of carrying the momentum forward.
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.
